In vitro demonstration of herbal exacerbation of paracetamol-induced hepatotoxicity

Ahmad, 2020, In vivo hepatoprotective potential of extracts obtained from floral spikes of Prunella vulgaris L, J. Ayurveda Integr. Med, 11, 502, 10.1016/j.jaim.2019.08.003 Ang, 2020, Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines, Integr. Med. Res., 9, 10.1016/j.imr.2020.100407 Born, 2000, O-hydroxyphenylacetaldehyde is a hepatotoxic metabolite of coumarin, Drug Metab. Dispos., 28, 218 Britza, 2020, Paracetamol (acetaminophen) hepatotoxicity increases in the presence of an added herbal compound, Leg. Med., 47, 10.1016/j.legalmed.2020.101740 Britza, 2022, Implications for herbal polypharmacy: coumarin-induced hepatotoxicity increased through common herbal phytochemicals astragaloside IV and atractylenolide I, Tox. Mech. Methods. Byard, 2017, What risks do herbal products pose to the Australian community?, Med. J. Aust., 206, 86, 10.5694/mja16.00614 Cairns, 2019, Paracetamol poisoning-related hospital admissions and deaths in Australia, Med. J. Aust., 211, 218, 10.5694/mja2.50296 Caparrotta, 2018, Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature, Eur. J. Clin. Pharmacol., 74, 147, 10.1007/s00228-017-2356-6 Cheng, 2011, Astragaloside IV protects against ischemia reperfusion in a murine model of orthotopic liver transplantation, Transplant. Proc., 43, 1456, 10.1016/j.transproceed.2011.02.066 Cheung, 2009, Liver injury associated with the use of Fructus Psoraleae (Bol-gol-zhee or Bu-gu-zhi) and its related proprietary medicine, Clin. Toxicol. (Phila)., 47, 683, 10.1080/15563650903059136 Choi, 2015, HepG2 cells as an in vitro model for evaluation of cytochrome P450 induction by xenobiotics, Arch. Pharm. Res., 38, 691, 10.1007/s12272-014-0502-6 Fisher, 2019, Evaluation and treatment of acetaminophen toxicity, Adv. Pharmacol., 85, 263, 10.1016/bs.apha.2018.12.004 Gerets, 2012, Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins, Cell Biol. Toxicol., 28, 69, 10.1007/s10565-011-9208-4 Ghanem, 2016, Acetaminophen from liver to brain: new insights into drug pharmacological action and toxicity, Pharmacol. Res., 109, 119, 10.1016/j.phrs.2016.02.020 Gromek, 2015, Pharmacovigilance of herbal medicines, Int. J. Risk Saf. Med., 27, 55, 10.3233/JRS-150643 Hai-Long, 2015, Some Chinese folk prescriptions for wind-cold type common cold, J. Tradit. Complement. Med., 5, 135, 10.1016/j.jtcme.2014.11.035 Hammer, 2021, Cross-species analysis of hepatic cytochrome P450 and transport protein expression, Arch. Toxicol., 95, 117, 10.1007/s00204-020-02939-4 Huang, 2019, Isobologram analysis: a comprehensive review of methodology and current research, Front. Pharmacol., 10.3389/fphar.2019.01222 Ji, 2015, Psoralen, a mechanism-based inactivator of CYP2B6, Chem. Biol. Interact., 240, 346, 10.1016/j.cbi.2015.08.020 Kalsi, 2011, Does cytochrome P450 liver isoenzyme induction increase the risk of liver toxicity after paracetamol overdose?, Open Access Emerg. Med., 3, 69 Kaur, 2018, Progression of conventional hepatic cell culture models to bioengineered HepG2 cells for evaluation of herbal bioactivities, Biotechnol. Lett., 40, 881, 10.1007/s10529-018-2547-y Khatune, 2004, Antibacterial compounds from the seeds of Psoralea corylifolia, Fitoterapia, 75, 228, 10.1016/j.fitote.2003.12.018 Koul, 2019, Genus Psoralea: a review of the traditional and modern uses, phytochemistry and pharmacology, J. Ethnopharmacol., 232, 201, 10.1016/j.jep.2018.11.036 Kurtovic, 2003, Paracetamol-induced hepatotoxicity at recommended dosage, J. Intern. Med., 253, 240, 10.1046/j.1365-2796.2003.01097.x Labsi, 2016, Antihydatic and immunomodulatory effects of Punica granatum peel aqueous extract in a murine model of echinococcosis, Asian Pac. J. Trop. Med, 9, 211, 10.1016/j.apjtm.2016.01.038 Labsi, 2019, A preventative effect of the combination of albendazole and pomegranate peel aqueous extract treatment in cystic echinococcosis mice model: an alternative approach, Acta Trop., 197, 10.1016/j.actatropica.2019.105050 Laine, 2009, Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes, Xenobiotica, 39, 11, 10.1080/00498250802512830 Lau, 2013, Effect of Chinese herbs on CYP3A4 activity and expression in vitro, J. Ethnopharmacol., 149, 543, 10.1016/j.jep.2013.07.014 Li, 2017, Bakuchiol contributes to the hepatotoxicity of Psoralea corylifolia in rats, Phytother. Res, 31, 1265, 10.1002/ptr.5851 Li, 2019, Acute liver failure associated with Fructus Psoraleae: a case report and literature review, BMC Complement. Altern. Med., 19, 2493 Liu, 2015, CYP3A4 inhibition of Psoralea corylifolia and its major components of human recombinant enzyme, differentiated human hepatoma HuH-7 and HepaRG cells, Toxicol. Rep., 2, 530, 10.1016/j.toxrep.2015.03.006 Liu, 2018, Incorporation of absorption and metabolism into liver toxicity prediction for phytochemicals: a tiered in silico QSAR approach, Food Chem. Toxicol., 118, 409, 10.1016/j.fct.2018.05.039 Luo, 2020, Analysis on herbal medicines utilized for treatment of COVID-19, Acta Pharm. Sin. B., 10, 1192, 10.1016/j.apsb.2020.05.007 Luo, 2020, Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs, Chin. J. Integr. Med., 26, 243, 10.1007/s11655-020-3192-6 Maher, 2014, Clinical consequences of polypharmacy in elderly, Expert Opin. Drug. Saf., 13, 57, 10.1517/14740338.2013.827660 Manyike, 2000, Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation, Clin. Pharmacol. Ther., 67, 275, 10.1067/mcp.2000.104736 McGill, 2013, Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis, Pharm. Res., 30, 2174, 10.1007/s11095-013-1007-6 Nam, 2005, A case of acute cholestatic hepatitis associated with the seeds of Psoralea corylifolia (Boh-Gol-Zhee), Clin. Toxicol. (Phila)., 43, 589, 10.1081/CLT-200068863 Nash, 2021, Drug-induced liver injury in Australia, 2009-2020: the increasing proportion of non-paracetamol cases linked with herbal and dietary supplements, Med. J. Aust., 10.5694/mja2.51173 Pergolizzi, 2020, COVID-19 and NSAIDS: a narrative review of knowns and unknowns, Pain Ther, 9, 353, 10.1007/s40122-020-00173-5 Sestili, 2020, Paracetamol-induced glutathione consumption: is there a link with severe COVID-19 illness?, Front. Pharmacol., 11, 10.3389/fphar.2020.579944 Shen, 2008, Rifampicin exacerbates isoniazid-induced toxicity in human but not in rat hepatocytes in tissue-like cultures, Br. J. Pharmacol., 153, 784, 10.1038/sj.bjp.0707611 Smith, 2016, Fulminant liver failure and transplantation after use of dietary supplements, Med. J. Aust., 204, 30, 10.5694/mja15.00816 Song, 2014, Pharmacokinetic interaction of astragaloside IV with atractylenolide I and prim-O-glucosylcimifugin in male Sprague Dawley rats, Planta Med, 80, 187 Song, 2019, The mechanism of psoralen and isopsoralen hepatotoxicity as revealed by hepatic gene expression profiling in SD rats, Basic Clin. Pharmacol. Toxicol., 125, 527, 10.1111/bcpt.13287 Liu, 2021, Clinical practice guideline on traditional Chinese medicine in the treatment of influenza (2021), J. Tradit. Chin. Med. Sci., 8, 280 Steel, 2018, Complementary medicine use in the Australia population: results of a nationally-representative cross-sectional survey, Sci. Rep., 8, 17325, 10.1038/s41598-018-35508-y Teschke, 2014, Review article: herbal hepatotoxicity - - an update on traditional Chinese medicine preparations, Aliment. Pharmacol. Ther., 40, 32, 10.1111/apt.12798 Thummel, 1993, Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4, Biochem. Pharmacol., 45, 1563, 10.1016/0006-2952(93)90295-8 Vitols, 2003, Paracetamol hepatotoxicity at therapeutic doses, J. Intern. Med., 253, 95, 10.1046/j.1365-2796.2003.01107.x Wang, 2011, Screening antitumor compounds psoralen and isopsoralen from psoralea corylifolia L. seeds, Evid. Based Complement. Alternat. Med., 10.1093/ecam/nen087 Wang, 2012, Evaluation of hepatotoxicity and cholestasis in rats treated with EtOH extract of Fructus Psoraleae, J. Ethnopharmacol., 144, 73, 10.1016/j.jep.2012.08.028 Wong, A., Graudins, A., 2017. Risk prediction of hepatotoxicity in paracetamol poisoning. Clin. Toxicol. (Phila). 55, 879–892. 10.1080/15563650.2017.1317349. Xin, 2010, Phytoestrogens from Psoralea corylifolia reveal estrogen receptor-subtype selectivity, Phytomedicine, 17, 126, 10.1016/j.phymed.2009.05.015 Yang, A., Chen, J., Ma, Y., Wang, L., Fan, Y., He, X., 2017. Studies on the metabolites difference of psoralen/isopsoralen in human and six mammalian liver microsomes in vitro by UHPLC-MS/MS. J. Pharm. Biomed. Anal. 141, 200–209. 10.1016/j.jpba.2017.04.026. Zhong, 2013, Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases, Kidney Int, 84, 1108, 10.1038/ki.2013.276